Quantitative pharmacologic responses of normal and atherosclerotic isolated human epicardial coronary arteries.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 6690108)

Published in Circulation on February 01, 1984

Authors

R Ginsburg, M R Bristow, K Davis, A Dibiase, M E Billingham

Articles citing this

L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest (1992) 2.35

Coronary vasospasm and sumatriptan. BMJ (1992) 1.33

Systems approach to understanding electromechanical activity in the human heart: a national heart, lung, and blood institute workshop summary. Circulation (2008) 1.17

Pharmacological reactivity of human epicardial coronary arteries: phasic and tonic responses to vasoconstrictor agents differentiated by nifedipine. Br J Pharmacol (1994) 1.02

Nitric oxide function in atherosclerosis. Mediators Inflamm (1997) 0.87

The influence of atherosclerosis on the mechanical responses of human isolated coronary arteries to substance P, isoprenaline and noradrenaline. Br J Pharmacol (1987) 0.82

Effects of cocaine on epicardial coronary artery reactivity in miniature swine after endothelial injury and high cholesterol feeding. In vivo and in vitro analysis. J Clin Invest (1991) 0.77

Vasoconstrictor and vasodilator effects in normal and atherosclerotic conscious rabbits. Br J Pharmacol (1988) 0.77

Novel Roles for Kv7 Channels in Shaping Histamine-Induced Contractions and Bradykinin-Dependent Relaxations in Pig Coronary Arteries. PLoS One (2016) 0.75

Endothelium is required in the vascular spasm induced by tetraethylammonium and endothelin-1 in guinea-pig aorta. Br J Pharmacol (1999) 0.75

[Effect of changed extracellular K(+) and Mg(2+)-concentration on intracellular Ca(2+) homeostasis, contraction coupling and force-frequency relations in the human myocardium]. Herz (1997) 0.75

Long-term spironolactone treatment reduces coronary TRPC expression, vasoconstriction, and atherosclerosis in metabolic syndrome pigs. Basic Res Cardiol (2017) 0.75

Mechanisms causing myocardial ischaemia. Can J Anaesth (1989) 0.75

Articles by these authors

Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science (1999) 36.25

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med (1996) 12.77

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet (1994) 11.37

Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med (1982) 6.79

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med (1995) 6.14

Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med (1998) 5.50

Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol (1987) 5.33

Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev (2002) 5.29

A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature (1988) 5.11

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis (1998) 4.50

Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med (1982) 4.40

Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med (1995) 4.12

Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol (2004) 4.12

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res (1986) 3.87

Population policy: will current programs succeed? Grounds for skepticism concerning the demographic effectiveness of family planning are considered. Science (1967) 3.55

Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med (2001) 3.44

Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med (1996) 3.41

Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation (1999) 3.35

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet (1993) 3.20

Uninsured and underserved: inequities in health care in the United States. Milbank Mem Fund Q Health Soc (1983) 3.16

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation (1996) 3.14

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol (1995) 3.12

Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet (1993) 3.10

Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res (2000) 3.08

Physicians' views on quality of care: a five-country comparison. Health Aff (Millwood) (2001) 3.00

The theory of change and response in modern demographic history. Popul Index (1963) 2.95

Complications of coronary arteriography from the Collaborative Study of Coronary Artery Surgery (CASS). Circulation (1979) 2.87

Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep (1978) 2.63

Congestive heart failure: fifty years of progress. Circulation (2000) 2.61

Insurance matters for low-income adults: results from a five-state survey. Health Aff (Millwood) (1997) 2.60

Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol (2001) 2.59

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med (1993) 2.39

Myosin heavy chain gene expression in human heart failure. J Clin Invest (1997) 2.39

Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation (1981) 2.36

Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant (1994) 2.36

Methods for microelectrode-guided posteroventral pallidotomy. J Neurosurg (1996) 2.30

Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest (1997) 2.29

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis (1999) 2.24

Some recent advances in cardiac pathology. Hum Pathol (1979) 2.17

Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol (1980) 2.17

Access to health care for the poor: does the gap remain? Annu Rev Public Health (1981) 2.17

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group. Neurology (1996) 2.13

Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest (1992) 2.07

Health insurance markets and income inequality: findings from an international health policy survey. Health Policy (2000) 2.04

Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum (2000) 2.01

Utilizing a line maintenance team to reduce central-line-associated bloodstream infections in a neonatal intensive care unit. J Perinatol (2011) 2.01

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation (1996) 2.01

Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation (1997) 2.00

The cost of health system change: public discontent in five nations. Health Aff (Millwood) (1999) 1.98

Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation (1986) 1.97

Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet (1997) 1.96

Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant (1990) 1.91

Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest (1984) 1.91

Models of arthritis and the search for anti-arthritic drugs. Pharmacol Ther (1983) 1.90

Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest (1988) 1.85

Diagnosis of human cardiac allograft rejection by serial cardiac biopsy. J Thorac Cardiovasc Surg (1973) 1.82

Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation (1997) 1.81

Transesophageal echocardiography and its potential for esophageal damage. Anesthesiology (1990) 1.80

Equal treatment and unequal benefits: the Medicare program. Milbank Mem Fund Q Health Soc (1975) 1.74

Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). Am J Cardiol (1981) 1.74

Cardiac transplant atherosclerosis. Transplant Proc (1987) 1.74

Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol (2001) 1.70

Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin Infect Dis (1995) 1.69

Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep (1978) 1.68

Penetrating cardiac trauma: a perioperative role for transesophageal echocardiography. Anesth Analg (1993) 1.68

Early anthracycline cardiotoxicity. Am J Med (1978) 1.63

Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci U S A (1990) 1.59

The nucleotide sequence of Saccharomyces cerevisiae chromosome XVI. Nature (1997) 1.58

Ictal neocortical slowing in temporal lobe epilepsy. Neurology (2004) 1.55

Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure. J Am Coll Cardiol (1998) 1.53

Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Am J Cardiol (1996) 1.52

Listening to parents. A national survey of parents with young children. Arch Pediatr Adolesc Med (1998) 1.52

Percutaneous transluminal laser angioplasty for treatment of peripheral vascular disease. Clinical experience with 16 patients. Radiology (1985) 1.51

Endocardial infiltrates in human heart transplants: a serial biopsy analysis comparing four immunosuppression protocols. Hum Pathol (1990) 1.50

Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies. J Thorac Cardiovasc Surg (1989) 1.49

Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease. Lancet (1991) 1.49

An activity in rat tissues that modifies nitrotyrosine-containing proteins. Proc Natl Acad Sci U S A (1998) 1.49

A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med (1992) 1.48

The accuracy of tympanic temperature measurement in children. Pediatr Nurs (1993) 1.48

Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Mol Med (2002) 1.47

High speed rotational coronary atherectomy for patients with diffuse coronary artery disease. J Am Coll Cardiol (1991) 1.47

Survival following cardiac transplantation--what are acceptable standards? West J Med (1987) 1.47

Surgical survival in the Coronary Artery Surgery Study (CASS) registry. Ann Thorac Surg (1985) 1.44

Disadvantages of prolonged propofol sedation in the critical care unit. Crit Care Med (1994) 1.44

Positive end-expiratory pressure and response to inhaled nitric oxide: changing nonresponders to responders. Surgery (2000) 1.44

Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation (1991) 1.43

Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. J Mol Cell Cardiol (2000) 1.43

Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol (1992) 1.42

Regulation of the mRNA-binding protein AUF1 by activation of the beta-adrenergic receptor signal transduction pathway. J Biol Chem (1996) 1.42

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation (1996) 1.41

Graft vascular disease in the great vessels and vasa vasorum. Hum Pathol (1993) 1.41

In situ hybridization studies for viral nucleic acids in heart and lung allograft biopsies. Am J Clin Pathol (1990) 1.41

Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis. Biochem J (1980) 1.40

Cost and complications during in-hospital transport of critically ill patients: a prospective cohort study. J Trauma (1992) 1.40